These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24330823)

  • 1. The therapeutic efficacy of I131-PSCA-mAb in orthotopic mouse models of prostate cancer.
    Yu S; Feng F; Wang K; Men C; Lin C; Liu Q; Yang D; Gao Z
    Eur J Med Res; 2013 Dec; 18(1):56. PubMed ID: 24330823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRl of prostate cancer antigen expression for diagnosis and immunotherapy.
    Ren J; Wang F; Wei G; Yang Y; Liu Y; Wei M; Huan Y; Larson AC; Zhang Z
    PLoS One; 2012; 7(6):e38350. PubMed ID: 22761679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody.
    Zettlitz KA; Tsai WK; Knowles SM; Kobayashi N; Donahue TR; Reiter RE; Wu AM
    J Nucl Med; 2018 Sep; 59(9):1398-1405. PubMed ID: 29602820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate stem cell antigen antibody-conjugated multiwalled carbon nanotubes for targeted ultrasound imaging and drug delivery.
    Wu H; Shi H; Zhang H; Wang X; Yang Y; Yu C; Hao C; Du J; Hu H; Yang S
    Biomaterials; 2014 Jul; 35(20):5369-5380. PubMed ID: 24709520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of immunoPET: using 124I-anti-PSCA A11 minibody for imaging disease progression and response to therapy in mouse xenograft models of prostate cancer.
    Knowles SM; Tavaré R; Zettlitz KA; Rochefort MM; Salazar FB; Jiang ZK; Reiter RE; Wu AM
    Clin Cancer Res; 2014 Dec; 20(24):6367-78. PubMed ID: 25326233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancer.
    Chu X; Shin S; Baek DS; Zhang L; Conard A; Shi M; Kim YJ; Adams C; Hines M; Liu X; Chen C; Sun Z; Jelev DV; Mellors JW; Dimitrov DS; Li W
    MAbs; 2024; 16(1):2387240. PubMed ID: 39113562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Zettlitz KA; Tsai WK; Knowles SM; Salazar FB; Kobayashi N; Reiter RE; Wu AM
    Mol Imaging Biol; 2020 Apr; 22(2):367-376. PubMed ID: 31209779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI of prostate stem cell antigen expression in prostate tumors.
    Ren J; Zhang Z; Wang F; Yang Y; Liu Y; Wei G; Yang A; Zhang R; Huan Y; Cui Y; Larson AC
    Nanomedicine (Lond); 2012 May; 7(5):691-703. PubMed ID: 22630152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
    Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
    Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Anti-Proliferative Effect of a Newly-Produced Anti-PSCA-Peptide Antibody by Multiple Bioinformatics Tools, on Prostate Cancer Cells.
    Chizari M; Fani-Kheshti S; Taeb J; Farajollahi MM; Mohsenzadegan M
    Recent Pat Anticancer Drug Discov; 2021; 16(1):73-83. PubMed ID: 33176663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanized radioiodinated minibody for imaging of prostate stem cell antigen-expressing tumors.
    Leyton JV; Olafsen T; Lepin EJ; Hahm S; Bauer KB; Reiter RE; Wu AM
    Clin Cancer Res; 2008 Nov; 14(22):7488-96. PubMed ID: 19010866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells.
    Arndt C; Feldmann A; Töpfer K; Koristka S; Cartellieri M; Temme A; Ehninger A; Ehninger G; Bachmann M
    Prostate; 2014 Sep; 74(13):1347-58. PubMed ID: 25053504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-Modality ImmunoPET/Fluorescence Imaging of Prostate Cancer with an Anti-PSCA Cys-Minibody.
    Tsai WK; Zettlitz KA; Tavaré R; Kobayashi N; Reiter RE; Wu AM
    Theranostics; 2018; 8(21):5903-5914. PubMed ID: 30613270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of [
    Tsai WK; Zettlitz KA; Dahlbom M; Reiter RE; Wu AM
    Mol Imaging Biol; 2020 Oct; 22(5):1380-1391. PubMed ID: 32661830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small interference RNA-mediated silencing of prostate stem cell antigen attenuates growth, reduces migration and invasion of human prostate cancer PC-3M cells.
    Zhao Z; Ma W; Zeng G; Qi D; Ou L; Liang Y
    Urol Oncol; 2013 Apr; 31(3):343-51. PubMed ID: 21429770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice.
    Hillerdal V; Ramachandran M; Leja J; Essand M
    BMC Cancer; 2014 Jan; 14():30. PubMed ID: 24438073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts.
    Saffran DC; Raitano AB; Hubert RS; Witte ON; Reiter RE; Jakobovits A
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2658-63. PubMed ID: 11226295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors.
    Lepin EJ; Leyton JV; Zhou Y; Olafsen T; Salazar FB; McCabe KE; Hahm S; Marks JD; Reiter RE; Wu AM
    Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1529-38. PubMed ID: 20354850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell-directed vaccination with a lentivector encoding PSCA for prostate cancer in mice.
    Xiao L; Joo KI; Lim M; Wang P
    PLoS One; 2012; 7(11):e48866. PubMed ID: 23139820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.